What is essential for the elimination of persistent or chronic atrial fibrillation?

Taijiro Sueda1

  • 1Department of Cardiovascular Surgery, Graduate School of Medicine, Hiroshima University, Hiroshima, Japan, sueda@hiroshima-u.ac.jp.

Surgery Today
|March 26, 2013
PubMed

Insights

The pulmonary vein box isolation effectively treats chronic atrial fibrillation (AF). Complete isolation of pulmonary veins is crucial for eliminating AF, building on earlier research into AF triggers and treatments.

Area of Science:

  • Cardiac Electrophysiology
  • Interventional Cardiology
  • Atrial Fibrillation Pathophysiology

Background:

  • Lone atrial fibrillation (AF) was historically treated with the maze procedure, based on the multiple reentry theory.
  • Ectopic foci originating from pulmonary veins were identified as triggers for paroxysmal AF.
  • Chronic AF involves complex electrophysiological substrates distributed around the pulmonary veins.

Purpose of the Study:

  • To demonstrate the efficacy of the pulmonary vein box isolation procedure for chronic atrial fibrillation (AF).
  • To emphasize the critical role of complete pulmonary vein isolation in AF elimination.

Main Methods:

  • Pulmonary vein box isolation procedure.
  • Utilizing insights from the maze procedure and ectopic foci discovery.
  • Application of complex fractionated atrial electrogram (CFAE) principles for substrate modification.

Main Results:

  • The pulmonary vein box isolation procedure proved effective in managing chronic AF.
  • Complete isolation of all pulmonary veins was demonstrated as essential for AF elimination.

Conclusions:

  • Pulmonary vein box isolation is a viable and effective strategy for chronic AF.
  • Complete isolation of pulmonary veins is a necessary condition for successful AF treatment.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...